Seek advice from your GP or trial clinician if diarrhoea is severe or prolonged
The monthly fee covers your provider visit, medication, and follow-up care
Women should seek prompt medical advice if they: Have been using retatrutide obtained from an unregulated or online source and experience any adverse symptoms Are pregnant, planning a pregnancy, or breastfeeding and have been offered or are considering retatrutide Have a history of thyroid cancer, pancreatitis, gallbladder disease, or eating disorders and are seeking weight management options Experience unexplained nausea, vomiting, severe abdominal pain, or changes in menstrual cycle while using any GLP-1-based therapy Red flag symptoms requiring urgent medical attention include: Severe or persistent abdominal pain (which may indicate pancreatitis or a gallbladder problem) call 999 or go to A&E if symptoms are severe or accompanied by systemic illness Signs of a serious allergic reaction such as facial swelling, difficulty breathing, or a widespread rash call 999 immediately Symptoms of hypoglycaemia (shakiness, sweating, confusion), particularly if taking other glucose-lowering medications Inability to keep fluids down, which may lead to dehydration and kidney problems seek same-day medical advice For women with obesity-related conditions such as PCOS, type 2 diabetes, or cardiovascular risk factors, a structured conversation with a GP or specialist is the safest starting point
In January 2025, the FDA approved an oral form of Novo Nordisks Wegovy (semaglutide) to treat obesity
Personally, I ordered a 15mg of Retatrutide vial from Evolve Peptides based on a recommendation from a very well-known biohacker and triathlete, and took the plunge
Individuals who screen positive or have a history of eating disorders should be referred to an obesity medicine specialist and an eating disorders specialist prior to prescribing GLP-1s
